WHO ICTRP trial
The efficacy and safety of Dazhu Rhodiola injection in the treatment of coronary…
ChiCTR2000036213 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2000036213 |
|---|---|
| Public title | The efficacy and safety of Dazhu Rhodiola injection in the treatment of coronary heart disease and angina pectoris: a randomized, open-label, multi-center real world clinical study |
| Scientific title | The efficacy and safety of Dazhu Rhodiola injection in the treatment of coronary heart disease and angina pectoris: a randomized, open-label, multi-center real world clinical study |
| Primary sponsor | The First Affiliated Hospital of Guangzhou University of Chinese Medicine |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Patients with coronary heart disease and angina pectoris, patients with heart blood stasis based on TCM differentiation |
| Interventions | Experimental group:According to the requirements of ACC/AHA coronary heart disease angina pectoris diagnosis and treatment guidelines, he received antiplatelet therapy, statins and nitrates. Rhodiola injection is 10ml once, diluted with… |
| Registration date | Aug 21, 2020 |
| Target size | Experimental group:600;Control group:600 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: